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More than 10 G protein-coupled receptors (GPCRs) have been reported to act as coreceptors for entry of human and
simian immunodeficiency viruses (HIV and SIV). We investigated the utilization of six GPCRs as coreceptors by T-cell-line-
adapted HIV-2 strains (CBL-20, CBL-21, CBL-23, GH-1, ROD, and SBL6669) and SIV strains (SIVagmTYO-1, SIVmac251, and
SIVmndGB-1). NP-2/CD4 cells were transduced with CCR3, CCR5, CCR8, CXCR4, GPR1, or APJ, and examined for suscep-
tibilities to cell-free HIV/SIV. HIV-2 strains were grouped into two types by their coreceptor usage. The first group, CBL-20
and CBL-21, used CXCR4 exclusively; the other four strains used a few or all of the six coreceptors. These strains could
further infect CD4-negative NP-2/CXCR4 or NP-2/CCR5 cells in the presence (all strains) or absence (SBL6669 and ROD
strains) of soluble CD4. SIVagm and SIVmnd infected NP-2/CD4/GPR1 cells. The coreceptors CCR3, CCR8, GPR1, and APJ
did not mediate the CD4-independent infection. Although HIV-2ROD and SIVmnd infected both NP-2/CD4/CXCR4 and
NP-2/CD4/CCR5 cells, only CXCR4 and CCR5, respectively, were used in CD4-independent infection. Binding of virions to
CD4-negative cells occurred at 4°C. These findings suggest that there may be a correlation between the promiscuous use
of coreceptors by HIV-2/SIV strains and their ability to infect CD4-negative cells. © 2000 Academic Press
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oINTRODUCTION
Human immunodeficiency virus (HIV) type 1 (HIV-1),
HIV type 2 (HIV-2), and simian immunodeficiency virus
(SIV) infect many types of target cells. The infection is
mediated by CD4 as the first receptor, and one of several
G protein-coupled receptors (GPCRs), especially chemo-
kine receptors such as CXCR4 and CCR5, as a corecep-
tor (Dimitrov, 1997). T-cell-line-tropic (T-tropic) HIV-1
strains use an a-chemokine receptor, CXCR4, as a core-
ceptor (X4 HIV-1) (Feng et al., 1996), while macrophage-
ropic (M-tropic) HIV-1 strains use a b-chemokine recep-
tor, CCR5, as a coreceptor (R5 HIV-1) (Alkhatib et al.,
1997; Choe et al., 1996; Doranz et al., 1996; Dragic et al.,
1996). Dual-tropic HIV-1 strains that can infect both T-cell
lines and macrophages efficiently use both CCR5 and
CXCR4 (R5X4 HIV-1) and occasionally other b-chemokine
eceptors, CCR2b and CCR3 (Choe et al., 1996; Doranz et
l., 1996; Simmons et al., 1996; Sol et al., 1997). Several T-
or M-tropic HIV-1 strains were also reported to use a
putative CKR, STRL33/Bonzo, as a coreceptor (Alkhatib et
al., 1996; Liao et al., 1997). Human cytomegalovirus
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276(CMV)-encoded CKR, US28, acts as a coreceptor for
several HIV-1 strains (Pleskoff et al., 1997). More recently,
it was reported that CCR8 is a coreceptor for diverse
HIV-1 and SIV strains (Jinno et al., 1998; Rucker et al.,
1997). We previously reported that CCR8 and GPR1 can
be used by a variant type of HIV-1, GUN1v, which was
adapted to replication in brain-derived fibroblast-like
BT-3 cells or a CD4-transduced glioma cell line, U87/CD4
(Jinno et al., 1998; Shimizu et al., 1999a). APJ, an orphan
eceptor, was previously identified as a coreceptor for
everal T-tropic and dual-tropic HIV-1 strains (Choe et al.,
998; Zhang et al., 1998).
HIV-2 strains were also shown to use several CKRs
such as CXCR4, CCR3, and CCR5 as coreceptors (Bron
et al., 1997; Sol et al., 1997). Like HIV-1 strains, primary
IV-2 isolates, which were propagated in cultured pe-
ipheral blood mononuclear cells from asymptomatic
arriers, use CCR5 or CCR3, but not CXCR4, while pri-
ary isolates from AIDS patients at advanced stages
se CXCR4, but not CCR3 and CCR5 (Sol et al., 1997). On
he other hand, there are reports showing that primary
IV-2 isolates can use a broad range of coreceptors,
ncluding CCR1, CCR2b, CCR3, CCR5, and CXCR4 (Bron
t al., 1997; McKnight et al., 1998). HIV-2ROD, a T-cell-
ine-adapted (T-tropic) isolate, is particularly promiscu-
us in coreceptor usage and induces fusion of CD4-
ositive cells expressing CCR1, CCR2b, CCR3, CCR5,
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277CD4-DEPENDENT AND CD4-INDEPENDENT INFECTION OF HIV/SIVCXCR2, or CXCR4 in cell–cell fusion assay, although it
uses CCR3 and CXCR4, but not CCR1, CCR2b, CXCR2, or
CCR5, in cell-free virus infection (Bron et al., 1997; McK-
night et al., 1998). ROD/B, a variant of HIV-2 that effi-
ciently infects some types of cells lacking CD4, uses
CXCR4, CCR3, or an orphan receptor V28 in the absence
of CD4 (Endres et al., 1996; Reeves et al., 1997). Further-
more, many primary HIV-2 strains were reported to infect
CCR5- or CXCR4-positive cells lacking CD4 (Reeves et
al., 1999). These data suggest that the patterns of core-
ceptor usage are more complex for HIV-2 than for HIV-1.
Infection of T cells with SIV strains can be inhibited by
natural CCR5 ligands, MIP-1a, MIP-1b, and RANTES
Cocchi et al., 1995), and thus CCR5 has been identified
o function as a coreceptor for SIV infection (Chen et al.,
997; Edinger et al., 1997a; Marcom et al., 1997). As for
coreceptor usage of cell-free viruses, the utilization of
the following was previously reported: CXCR4 by
SIVmndGB-1 (Schols and De Clercq, 1998); CCR5 by
several SIVs (Chen et al., 1997; Edinger et al., 1997a;
arcom et al., 1997); CCR8 by SIVmac316 and
IVmac17E-Fr (Rucker et al., 1997); STRL33/BONZO by
IVmac239, SIVmac1A11, and SIVagmTYO-1 (Alkhatib et
l., 1997; Deng et al., 1997); GPR1 by SIVmac239 (Farzan
t al., 1997); and GPR15 by SIVmac239, SIVmac1A11, and
IVagmTYO-1 (Deng et al., 1997; Farzan et al., 1997). In
ddition, APJ has been identified to act as a coreceptor
or SIVmac316 infection (Choe et al., 1998). Moreover, the
eurovirulent strain SIVmac/17E-Fr can replicate well in
rain capillary endothelial cells lacking CD4 (Mankowski
t al., 1994): CCR5 acts as a primary receptor, i.e., CD4-
ndependent receptor, for this infection (Edinger et al.,
997b). These reports indicate that the GPCR usage as a
oreceptor and the requirement of CD4 as a primary
eceptor are complicated not only for HIV-2 but also for
IV infection. In cell–cell fusion assays, coreceptor us-
ges of HIV/SIV strains have been reported to be wider
han those in infection assays of cell-free viruses.
To more precisely examine the roles of CD4 and
PCRs in the infection with T-cell-line-adapted (T-tropic)
IV-2 and SIV strains, we infected various NP-2 and
P-2/CD4 cell lines, previously introduced with one of
he coreceptors (Soda et al., 1999), with several HIV-2
nd SIV strains. The results showed that all HIV-2 strains
hat used multiple GPCRs as coreceptors infected CD4-
egative cells in the presence of soluble CD4 (sCD4),
nd that only CCR5 or CXCR4 acted as a cellular CD4-
ndependent coreceptor for promiscuous HIV-2 strains or
IVmnd.
RESULTS
esistance of NP-2 and NP-2/CD4 cells to HIV-1, HIV-
, and SIV entryTo determine the coreceptor usage of HIV-1 (Ba-L, IIIB,
nd GUN1v), HIV-2 (CBL-20, CBL-21, CBL-23, GH-1, ROD,nd SBL6669), or SIV (agm, mac, and mnd) strains using
P-2 and NP-2/CD4 cells, we examined whether these
ells were resistant to infection with these viruses. Viral
ntigens were not expressed in these cells after infec-
ion of HIV-1, HIV-2, or SIV (Fig. 1) as previously described
n part (Soda et al., 1999). Virus entry into NP-2 and
P-2/CD4 cells was further determined by PCR amplifi-
ation using specific primers for HIV/SIV. No signal was
etected after infection of NP-2 and NP-2/CD4 cells with
hree HIV-1, six HIV-2, or three SIV strains, while b-globin-
specific bands were detected after PCR of each sample
(data not shown). Thus NP-2 and NP-2/CD4 cells were
confirmed by PCR to be resistant to all of the HIV-1, HIV-2,
and SIV strains used in this study.
Establishment of GPCR-expressing NP-2
and NP-2/CD4 sublines
NP-2/CD4 sublines stably expressing one of the hu-
man GPCRs, CCR3, CCR5, CCR8, CXCR4, GPR1, or APJ,
were established as described elsewhere (Jinno et al.,
1998; Soda et al., 1999). CD4-negative NP-2 sublines
expressing one of these GPCRs were also established in
a similar way. The expression of CCR3, CCR5, CCR8,
CXCR4, GPR1, or APJ mRNA was confirmed by RT-PCR to
detect their specific mRNA (data not shown). Using anti-
CD4 (Nu-TH/I), anti-CXCR4 (12G5), anti-CCR3 (7B11), or
anti-CCR5 (2D7) monoclonal antibody (MAb), we further
evaluated the expression of CD4, CXCR4, CCR3, or CCR5
on these NP-2 and NP-2/CD4 sublines by flow cytometry
(FCM) (Table 1). FCM results showed that transduced
genes CD4, CCR3, CCR5, and CXCR4 were specifically
expressed on the surface of NP-2 and NP-2/CD4 sub-
lines as described previously (Soda et al., 1999), sug-
gesting that our system to express CCR8, GPR1, and APJ
also functioned well.
Coreceptors for infection of HIV-2 strains
We confirmed that NP-2/CD4 cells expressing CCR3,
CCR5, CCR8, CXCR4, or GPR1 showed expected sus-
ceptibilities to HIV-1 strains (Table 2 and Fig. 1) as
previously reported (Shimizu et al., 1999a; Soda et al.,
1999). APJ was not used by these three HIV-1 strains
(Fig. 1).
Next we examined GPCR usages of six HIV-2
strains. IFA performed within 10 days after infection
showed that the abilities of these viruses to infect
GPCR-expressing NP-2/CD4 sublines varied markedly
(Fig. 1). That is, dual (T- and M-)-tropic CBL-20 and
CBL-21 strains only plated onto NP-2/CD4/CXCR4
cells, but not onto NP-2/CD4/CCR5 cells at all, while
CBL-23, GH-1, ROD, and SBL6669 strains used multi-
ple GPCRs, such as CCR3, CCR5, CCR8, CXCR4, GPR1,
or APJ as coreceptors. CBL-23 and ROD strains effi-
ciently infected all sublines including NP-2/CD4/APJ
cells. GH-1 and SBL6669 strains showed different
own. H
278 LIU ET AL.types of infectivities. The GH-1 strain efficiently used
CCR5, CCR8, and GPR1, but not CXCR4, CCR3, or APJ
(Fig. 1). The SBL6669 strain efficiently infected NP-2/
CD4 cells expressing CCR3 or CXCR4, and to a lesser
extent NP-2/CD4 cells expressing CCR8, GPR1, or APJ.
Furthermore, this strain did not plate onto NP-2/CD4/
CCR5 cells at all (Fig. 1). Thus APJ functioned well as
an HIV-2 coreceptor.
FIG. 1. Infection of GPCR-expressing NP-2/CD4 sublines with HIV-2,
seeded at 3–4 3 104 cells per well and inoculated with each virus s
NP-2/CD4 cells transduced with CXCR4, CCR3, CCR5, CCR8, GPR1, or A
slide glasses and fixed, and infection (percentages of viral antigen-pos
were counted. Highest values (means 6 SD) for each infection are sh
infection.
T
Expression of CD4 and Chemokine Receptors on the S
Subline Anti-CD4a Anti-CCR3
NP-2 2b 2
NP-2/CCR3 2 85 6 8
NP-2/CCR5 2 2
NP-2/CXCR4 2 2
NP-2/CD4 77 6 3 2
NP-2/CD4/CCR3 81 6 2 88 6 7
NP-2/CD4/CCR5 70 6 6 2
NP-2/CD4/CXCR4 76 6 6 2
Note. Ratios of antigen-positive cells (%) (means 6 SD) were determ
a Monoclonal antibodies (MAbs) used were as follows: anti-CD4, Nu-TH/I;
b 2, negative (,5%).Syncytium formation after infection with HIV-2
Since the coreceptors are used for cell fusion, we
assessed the syncytium formation activities of the HIV-2
strains. The cultures with high percentages (e.g., .30%)
of viral antigen-positive cells always showed marked
syncytium formation, whereas weakly infected cells (e.g.,
,10% positive) formed a few syncytia as summarized in
d HIV-1. NP-2, NP-2/CD4, and GPCR-expressing NP-2/CD4 cells were
A) HIV-2; (B) SIV; (C) HIV-1. As GPCR-expressing CD4-positive cells,
re used. After incubation for 5 to 10 days, the cells were smeared onto
lls) was determined by IFA. More than 500 cells in three different fields
ighly susceptible cells were markedly damaged before 10 days after
of NP-2 Sublines Detected by Monoclonal Antibodies
Anti-CCR5 Anti-CXCR4 MAb (2)
2 2 2
2 2 2
99 6 1 2 2
2 94 6 7 2
2 2 2
2 2 2
100 2 2
2 100 2
y flow cytometry as described under Materials and Methods.SIV, an
train: (
PJ we
itive ceABLE 1
urface
ined b
anti-CCR3, 7B11; anti-CCR5, 2D7; anti-CXCR4, 12G5.
d279CD4-DEPENDENT AND CD4-INDEPENDENT INFECTION OF HIV/SIVTable 2. Virus production into culture fluids after infection
with HIV-2 was detectable by RT assays (data not
shown). The results of syncytium formation assays (Table
2) and those of RT assays were well correlated with
those of IFA shown in Fig. 1.
Coreceptors for infection of SIVs
We then investigated whether GPCR-expressing NP-
2/CD4 sublines were also susceptible to infection by
three SIV strains, SIVagmTYO-1, SIVmac251, and
SIVmndGB-1. As shown in Fig. 1, high percentages of
CCR5- or GPR1-expressing cells inoculated with
SIVagm, SIVmac, and SIVmnd were IFA-positive for
viral antigens. SIVmnd also replicated well in NP-2/
CD4/CXCR4 cells as reported (Schols and De Clercq,
1998) and poorly in NP-2/CD4/APJ, NP-2/CD4/CCR3,
and NP-2/CD4/CCR8 cells. SIVagm infected NP-2/CD4/
CXCR4 cells with a low efficiency (IFA-positive cells,
10%) (Fig. 1).
Numerous syncytia were formed in CCR5- or GPR1-
expressing NP-2/CD4 cells infected with all three SIV
strains and in NP-2/CD4/CXCR4 cells infected with
SIVmnd, as summarized in Table 2. Productive infection
of NP-2/CD4 sublines with SIV was also confirmed by RT
T
Syncytium Formation in NP-2 and NP-2/CD4 Cells E
Cell
HIV-2
CBL-20 CBL-21 CBL-23 GH-1 ROD
NP-2/CD4 2a 2 2 2 2
NP-2/CD4/CCR3 2 2 1111 1 1111
NP-2/CD4/CCR5 2 2 1111 1111 1111
NP-2/CD4/CCR8 2 2 111 1111 1111
NP-2/CD4/CXCR4 1111 1111 1111 1 1111
NP-2/CD4/GPR1 2 2 1111 1111 1111
NP-2/CD4/APJ 2 2 111 11 1111
NP-2 2 2 2 2 2
NP-2/CCR3 2 2 2 2 2
NP-2/CCR5 2 2 2 2 2
(11)b
NP-2/CCR8 2 2 2 2 2
NP-2/CXCR4 2 2 2 2 1111
(1)b [1111]c [
NP-2/GPR1 2 2 2 2 2
NP-2/APJd 2 2 2 2 2
Note. Results of syncytium formation assay were consistent with tho
all of the CD4-negative sublines were examined and only positive res
a Symbols: 2, negative results (no syncytium); 1, 1–50; 11, 50–100
ays after infection.
b Syncytium formation only in the presence of human sCD4 at 10 mg
c Syncytium formation in the presence and absence of sCD4.
d NP-2/APJ cells were examined only in the absence of sCD4.assays of culture supernatants of inoculated cells (data
not shown).CCR5-mediated, CD4-independent infection of SIVmnd
and HIV-2GH-1
CCR5 has been shown to facilitate the CD4-indepen-
dent infection of brain capillary endothelial cells with the
SIVmac/17E-Fr strain (Edinger et al., 1997b). We thus
investigated the CCR5 usage of HIV-2 and SIV strains in
a CD4-independent manner. Although CCR5 has been
reported not to function as a coreceptor for SIVmndGB-1
(Schols and De Clercq, 1998), the SIVmnd strain was
found to efficiently infect NP-2/CCR5 cells in the pres-
ence or absence of sCD4 (Fig. 2A). The HIV-2 strain GH-1
infected NP-2/CCR5 cells only in the presence of sCD4
(Fig. 2A). Large and small syncytia were formed in NP-
2/CCR5 cells after infection with SIVmnd and HIV-2GH-1,
respectively (Fig. 2B, panels b and c). RT assays also
showed that NP-2/CCR5 cells were productively infected
with SIVmnd, whereas infection of NP-2/CCR5 cells with
HIV-2GH-1 required the presence of sCD4 (Fig. 3).
CXCR4 as a primary receptor for HIV-2 strains
CXCR4 has been reported to act as a primary receptor
for the ROD strain of HIV-2 (Endres et al., 1996; Reeves et
al., 1997). Two out of six HIV-2 strains, ROD and SBL6669,
efficiently infected CD4-negative NP-2/CXCR4 cells (Fig.
ing GPCRs after Infection with HIV-1, HIV-2 or SIV
SIV HIV-1
Mock9 agm mac mnd Ba-L IIIB GUN1v
2 2 2 2 2 2 2
2 2 1 2 2 1111 2
1111 1111 1111 1111 2 1111 2
2 2 1 2 2 111 2
1 2 1111 2 1111 1111 2
1111 1111 1111 2 2 111 2
2 2 11 2 2 2 2
2 2 2 2 2 2 2
2 2 2 2 2 2 2
2 2 1111 2 2 2 2
[1111]c
2 2 2 2 2 2 2
2 2 2 2 2 2 2
]c
2 2 2 2 2 2 2
2 2 2 2 2 2 2
FA shown in Figs. 1 and 2. As for cellular CD4-independent infection,
shown.
, 100–200, 1111, .200 syncytia per well in 12-well plates during 10ABLE 2
xpress
SBL666
2
111
2
11
1111
111
11
2
2
2
2
1111
1111
2
2
se of I
ults are
, 111
/ml.2A). The CBL-23 strain did infect NP-2/CXCR4 cells in the
presence of sCD4, but with a low efficiency (Fig. 2A).
i
I
i
T
i
i
S
i
IV-2 st
280 LIU ET AL.Numerous syncytia were observed in NP-2/CXCR4 cells
infected with the ROD and SBL6669 strains (Fig. 2B,
panels e and f). RT assays also showed that NP-2/CXCR4
cells were productively infected with HIV-2 (Fig. 3). These
results indicate that the NP-2 cell system functioned well
for analyses of CD4-independent infection of HIV/SIV.
HIV-2CBL-20 and HIV-2CBL-21, and two SIV strains
(agm and mac) as well as three HIV-1 strains did not
infect NP-2/CXCR4 or NP-2/CCR5 cells (Fig. 2A). NP-2/
CCR3, NP-2/CCR8, NP-2/GPR1, or NP-2/APJ cells were
resistant to all of the HIV/SIV strains we tested (Table 2,
and data not shown). Thus, only NP-2/CCR5 and NP-2/
CXCR4 cells were susceptible to some HIV-2 and SIV
strains in the presence or absence of sCD4.
Inhibition of CD4-independent infection by monoclonal
antibodies
Anti-CCR5 MAb showed over 95% inhibition of the
infection of NP-2/CCR5 cells with the SIVmnd strain at 1
mg/ml, while the anti-CXCR4 MAb 12G5 exhibited little
inhibitory effect on this infection (Fig. 4A). Next, we in-
vestigated the inhibitory effects of CCR5 ligands on in-
fection of NP-2/CCR5 cells with SIVmnd. As shown in Fig.
4B, MIP-1a, MIP-1b, and RANTES at 250 ng/ml markedly
nhibited the infection of NP-2/CCR5 cells with SIVmnd.
FIG. 2. Susceptibilities of CD4-negative NP-2 sublines to infection w
nfected with HIV-1 (Ba-L, IIIB, or GUN1v), HIV-2, or SIV in the presence
of virus antigen-positive cells were determined between 5 and 10 days
NP-2/CCR5 and NP-2/CXCR4 cells were infected with SIVmnd (b), or H
cells were fixed and stained with Giemsa.n contrast, a natural ligand for CCR3, eotaxin, had little
nhibitory effect on the infection of SIVmnd (Fig. 4B).hese findings indicate that CCR5 was really used in the
nfection of NP-2/CCR5 cells with SIVmnd.
The anti-CXCR4 MAb 12G5 was confirmed to block the
nfection of NP-2/CXCR4 cells with both ROD and
BL6669 strains (Fig. 4C): 12G5 MAb at 5 mg/ml mark-
edly inhibited the infection of NP-2/CXCR4 cells with
either ROD or SBL6669 strain. Anti-CCR5 MAb 2D7 had
little effect on this infection (Fig. 4).
Effect of low temperature on CD4-independent
infection
NP-2/CD4/CXCR4 or NP-2/CXCR4 cells were inocu-
lated with HIV-2ROD or SIVmnd at either 37 or 4°C and
incubated for 1 h. The cells were washed extensively and
cultured for up to 10 days. NP-2/CD4/CXCR4 cells were
infected with both virus strains: their plating was several-
fold more efficient at 37°C than at 4°C (Fig. 5A). As for
CD4-independent infection, only HIV-2ROD plated onto
NP-2/CXCR4 cells: the virus bound to CD4-negative NP-
2/CXCR4 cells even at 4°C (Fig. 5B), suggesting that
conformational change of Env protein might not be nec-
essary for virus binding, because such changes can
hardly be expected to occur at 4°C. The plating efficiency
of HIV-2ROD to CD4-negative NP-2/CD4 cells was also
several-fold higher at 37°C than at 4°C (Fig. 5B).
-1, HIV-2, and SIV strains. (A) NP-2/CCR5 and NP-2/CXCR4 cells were
ence of 10 mg per ml of human soluble CD4 (sCD4). The percentages
fection. (B) Syncytium formation in NP-2/CCR5 and NP-2/CXCR4 cells.
rains, GH-1 (c), ROD (e), or SBL6669 (f). Mock infection (a and d). Theith HIV
or abs
after inNext NP-2/CD4/CCR5 and NP-2/CCR5 cells were in-
oculated with HIV-2ROD or SIVmnd at either 37 or 4°C:
sence
n Day
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than at 4°C (Figs. 5C and 5D) Only SIVmnd plated onto
CD4-negative NP-2/CCR5 cells (Fig. 5D). Thus, HIV-2ROD
and SIVmnd could use both CXCR4 and CCR5 as core-
ceptors in the presence of cellular CD4 (Figs. 5A and 5C),
but only CXCR4 and CCR5, respectively, functioned as
entry factors in CD4-independent infection (Figs. 5B and
5D).
More important, there was a difference in the infection
efficiency between CCR5- and CXCR4-expressing NP-2
cells by HIV-2ROD and SIVmnd. HIV-2ROD plated about
10-fold more efficiently onto NP-2/CD4/CXCR4 cells than
onto NP-2/CD4/CCR5 cells, whereas SIVmnd plated
much more efficiently onto NP-2/CD4/CCR5 cells than
onto NP-2/CD4/CXCR4 cells (Figs. 5A and 5C). These
findings suggest that the most efficient coreceptor in a
CD4-dependent infection can be a CD4-independent co-
receptor.
Cell-to-cell infection of CD4-negative cells
In CD4-independent infection of cell-free viruses, HIV-
FIG. 3. Replication of HIV-2 and SIV in CD4-negative NP-2 subline
indicated strains of HIV-2, SIV, or HIV-1 in the absence (A and C) or pre
SD) in culture supernatants harvested in duplicate were determined o2ROD and SIVmnd used only CXCR4 and CCR5, respec-
tively, but not both as the primary receptor (Fig. 5). Nextwe examined whether the cells are resistant to HIV-2 or
SIV when they are cocultured with HIV-2- or SIV-produc-
ing cells. C8166 cells were infected with either HIV-2ROD
or SIVmnd. NP-2/CXCR4 and NP-2/CCR5 cells as well as
NP-2/CD4 and NP-2 cells were cocultured with infected
C8166 cells. Twelve days after cocultivation, most if not
all C8166 cells were lysed and disappeared. Then cell
smears were made and examined by IFA. Almost all
NP-2/CXCR4 and NP-2/CCR5 cells were infected with
HIV-2ROD and SIVmnd, respectively (Fig. 6). Next C8166/
CCR5 cells were infected with HIV-2ROD and coculti-
vated with NP-2/CXCR4, NP-2/CCR5, or NP-2/CCR3 cells.
Most, and only, NP-2/CXCR4 cells were positive for HIV-2
antigens by 4–8 days after coculture (data not shown).
Even in cell-to-cell infection of HIV-2/SIV, only CCR5 and
CXCR4 functioned as a CD4-independent receptor for
SIVmnd and HIV-2ROD, respectively.
V3 loop sequences of HIV-2/SIV and their coreceptor
usages
To identify amino acids in the V3 loop, which is critical
/CCR5 (A and B) or NP-2/CXCR4 (C and D) cells were infected with
(B and D) of sCD4 as described in Fig. 2. RT activities (cpm) (means 6
0 (2 h after infection), Day 3, or Day 5 after infection.s. NP-2for the determination of coreceptor usage, we se-
quenced the V3 loops of all of the HIV-2/SIV strains used
T
S
w
r
m
282 LIU ET AL.in this study (Table 3). The V3 DNA sequences (three
clones from each strain) derived from HIV-2/SIV strains
that had been maintained in our laboratory were identi-
cal to those present in the GenBank database (data for
the CBL-20 strain are not available), except that one
amino acid residue in the ROD strain was different from
the reported sequence of ROD (Table 3). GH-1 and
CBL-23 strains with a few amino acid substitutions from
FIG. 4. Inhibitory effects of monoclonal antibodies and CCR5
ligands on infection of SIVmnd and HIV-2. NP-2/CCR5 (A and B) and
NP-2/CXCR4 (C) cells were preincubated with anti-CCR5 MAb, 2D7,
anti-CXCR4 MAb, 12G5, or CCR5 ligands, MIP-1a, MIP-1b, or RAN-
ES, at the indicated concentrations, and then were infected with
IVmnd (A and B) or HIV-2 (ROD or SBL6669) (C). Inhibition rates (%)
ere calculated as described under Materials and Methods. Rep-
esentative data of one experiment from three independent experi-
ents are shown.the consensus sequences of HIV-2 V3 were able to use
multiple coreceptors. We could not point out a specificamino acid or a specific site that could be important for
determination of coreceptor usage.
DISCUSSION
A T-tropic HIV-1 strain, IIIB, used only CXCR4 as an
efficient coreceptor, and an M-tropic HIV-1 strain, Ba-L,
used CCR5 as a coreceptor (Fig. 1). The HIV-1GUN1v
strain used multiple GPCRs as coreceptors (Fig. 1 and
Table 2) as reported (Shimizu et al., 1999a,b; Soda et al.,
1999). In the case of HIV-2, we observed that all six HIV-2
strains replicated well in T-cell lines, such as C8166 or
Molt-4, and macrophages (data not shown), but CBL-20
and CBL-21 strains used CXCR4 but not CCR3 or CCR5.
The other strains, CBL-23, GH-1, ROD, and SBL6669,
used several coreceptors, such as CXCR4, CCR3, CCR5,
CCR8, GPR1, or APJ, but the SBL6669 strain could not use
CCR5. Thus, the usage by HIV-2 strains of coreceptors
expressed in NP-2/CD4 cells does not appear to be well
correlated with the cell tropism for macrophages. By the
use of findings shown in Fig. 1 and Table 2, T-cell-line-
adapted (T-tropic) HIV-2 strains can be grouped into two
types according to their abilities to infect NP-2/CD4 sub-
lines expressing GPCRs. The first group including
CBL-20 and CBL-21 is X4 HIV-2, and the second group is
promiscuous for coreceptor usage: SBL6669 and GH-1
strains are moderately promiscuous and CBL-23 and
ROD strains are highly promiscuous.
Although three SIV strains, SIVagm, SIVmac, and
SIVmnd, also replicated well in C8166 or Molt-4 T-cell
lines, only SIVmnd efficiently used CXCR4 as a corecep-
tor for infection (Fig. 1) as reported (Schols and De
Clercq, 1998). CCR5, which is not expressed in either
Molt-4 or C8166 cells, was shown to function as a core-
ceptor for almost all SIV strains (Chen et al., 1997;
Edinger et al., 1997a; Marcon et al., 1997), except for
SIVmnd (Schols and De Clercq, 1998). These findings
suggest that an alternative coreceptor should also be
used for infection of T-cell lines with SIVs. It has been
reported that GPR1 is a coreceptor for SIVmac infection
(Farzan et al., 1997) and is a cell–cell fusion factor for
SIVagm (Edinger et al., 1998). In this study, cell-free
SIVagm and SIVmnd were shown to efficiently use GPR1
as a coreceptor (Fig. 1). Other GPCRs such as CXCR4,
CCR3, CCR8, or APJ did not act as efficient coreceptors
for SIVagm and SIVmac (Fig. 1). GPR1 was found to be
expressed in C8166 T cells (Shimizu et al., 1999a). There-
fore GPR1 may play an important role in infection of T-cell
lines or primary T cells with SIVagm and SIVmnd as well
as SIVmac.
Recently, CCR5 was reported to function as a primary
receptor for the neurovirulent SIVmac/17E-Fr strain
(Edinger et al., 1997b). In this study we found that
SIVmnd, but neither SIVmac nor SIVagm, could use CCR5
to infect NP-2 cells lacking CD4 (Figs. 1–3), although
these viruses could efficiently infect NP-2/CD4/CCR5
i at eith
v days.
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that of both SIVagm and SIVmac (Table 2 and Fig. 1).
HIV-2GH-1 also used CCR5 to infect CD4-negative NP-2
cells, but it required sCD4 (Fig. 2). Although CXCR4,
CCR3, CCR5, CCR8, GPR1, or APJ was shown to be the
coreceptor for some HIV-2 or SIV strains, only CXCR4
and CCR5 functioned as primary receptors for HIV-2 or
SIV when expressed in CD4-negative NP-2 cells (Table
2). Although HIV-1GUN1v was very promiscuous (as
shown in Fig. 1), this strain, as well as other promiscuous
HIV-1 strains (data not shown), always required cellular
CD4 for entry, so far as we tested.
Dependency of specific coreceptors, either CXCR4 or
CCR5, on the establishment of CD4-independent infec-
tion was strict. Although HIV-2ROD and SIVmnd effi-
ciently used both CXCR4 and CCR5 in the presence of
cellular CD4, only one of them functioned as a CD4-
independent coreceptor (Figs. 5 and 6). This may not be
determined by the amounts of viruses inoculated to tar-
get cells, because even cell-to-cell infection could not
overcome this restriction (Fig. 6).
Plating efficiencies of HIV-2ROD and SIVmnd at 4°C
were about 10-fold lower than those at 37°C in the
presence of CD4 or even in the absence of CD4 (Fig. 5).
FIG. 5. Effect of low temperature on HIV/SIV infection. NP-2/CD4/CX
nfected with HIV-2ROD (broken lines) or SIVmnd (solid lines) for 1 h
iruses, the cells were washed extensively and incubated for up to 10At 4°C the conformational change of Env protein is
hardly thought to take place. This change ensures acoreceptor-binding region of these viruses to be ex-
posed on the surface of virions. The surface structure of
Env proteins of these virus strains, which use CCR5 or
CXCR4 in the CD4-independent way, may be different
from that of viruses which require CD4 for the entry. Our
findings suggest that a CXCR4-binding region of HIV-
2ROD and a CCR5-binding region of SIVmnd, but not the
other coreceptor-binding regions, may be exposed on
the surface of virions. Two possibilities may explain the
difference in recognition of coreceptors by the HIV-2/SIV
strains in the absence of CD4: (1) the region of Env
protein that binds to CXCR4 or CCR5 is different from
strain to strain; and (2) the binding affinity of an exposed
region of Env protein of each virus strain to a GPCR is
different and critical, and a specific combination showing
a high enough affinity will function as a coreceptor.
There may be correlation between the promiscuity of
HIV-2 strains and the cellular CD4-independent infection.
In this study four out of four promiscuous HIV-2 strains,
but neither of two X4 HIV-2 strains, could infect CCR5- or
CXCR4-positive, CD4-negative NP-2 cells in the pres-
ence of sCD4. Nevertheless, the SBL6669 strain that was
less promiscuous in coreceptor usage than the CBL-23
strain (Fig. 1) did efficiently infect NP-2/CXCR4 cells in
, NP-2/CXCR4 (B), NP-2/CD4/CCR5 (C), and NP-2/CCR5 (D) cells were
er 37°C (open symbols) or 4°C (closed symbols). After adsorption of
Viral antigen-positive cells (%) were detected by IFA.CR4 (A)the absence of sCD4, whereas the CBL-23 strain re-
quired sCD4, and its infection efficiency was still much
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284 LIU ET AL.lower than that of the SBL6669 strain (Fig. 2A). In general,
there seems to be a tendency that a virus which can use
multiple coreceptors is likely to infect cells in a CD4-
independent way.
The V3 domain of the HIV-1 gp120 has been shown to
be critical for b-chemokine-mediated blockade of infec-
ion (Cocchi et al., 1996). This region was then demon-
FIG. 6. Cell-to-cell infection of HIV-2 and SIV. C8166 human T cells
(2 3 104) that had been acutely infected with HIV-2ROD and SIVmnd
and incubated for 3 days were overlayed onto NP-2, NP-2/CD4, NP-2/
CXCR4, or NP-2/CCR5 cells (1 3 105). Twelve days after coculture,
almost all C8166 cells were judged to be lysed as a result of cell
damage, and then NP-2 sublines were examined for expression of
HIV-2 or SIVmnd antigens by IFA.
T
The V3 Sequences of HIV-2
Virus V3 sequence (N9 3 C9)
HIV-2 Consensus CKRNGNKTVVPITLMSGL?FHS––QP-INKRPRQAW
1. CBL-20 ---------L----G--HR--A..--I-S-.-----
CBL-21 -----------------HR---..R-V--RK-M---
2. SBL6669 -R--E------------RR---..-KI---K-----
3. GH-1 ------------------V---..--.--T------
4. CBL-23 ------------------R---..--V---------
5. ROD --------V-KQ-M---HV---HY--.---------
SIV
1. agmTYO-1 -R-P-----L-VTI-A--V------K-Y-M-L----
2. mac251 -R-P-----L-VTI----V----------DR-K---
3. mndGB-1 -H-K--RS--STPSAT--L-YHGLE---G-NLKKGM
Note. HIV-2 and SIV sequences were determined as described in M
matches that of the consensus sequence; Dots are introduced to main
from the reported sequence (Clavel et al., 1986). Coreceptor activities
ummarized: 2, negative; 1, weakly positive; 11, markedly positive.
usages.
a Soluble CD4-dependent infection.trated to be important in CCR5 usage by HIV-1: chimeric
iruses containing the V3 region of an NSI virus on an SI
irus background were shown to use CCR5 (Bieniasz et
l., 1997; Choe et al., 1996). These reports indicate that
he V3 domain is important for the coreceptor usage. We
reviously reported that the point mutations of proline at
he tip of the V3 glycine-proline-glycine-arginine (GPGR)
equence are responsible for determination of the cell
ropism of HIV-1 (Shimizu et al., 1994, 1999b; Takeuchi et
l., 1991). HIV-1 with the GPGR, GRGR, or GLGR se-
uence, does not infect brain-derived cells, while HIV-1
hat is infectious to U87/CD4 glioma cells has either the
AGR, GSGR, or GTGR sequence. The latter three mu-
ants use GPR1 as a coreceptor (Shimizu et al., 1999a).
BL-23, GH-1, ROD, and SBL6669, but not CBL-20 or
BL-21, used GPR1 as a coreceptor (Fig. 1, Table 2).
owever, we could not identify a specific amino acid
hange that would explain the GPR1 usage by HIV-2 and
IV strains (Table 3).
A recent study showed that the V1/V2 region of HIV-1
nd the V3 loop are both necessary and sufficient to
onfer CCR3-tropism (Ross and Cullen, 1998). The amino
cid sequences of the V3 regions of HIV-2 and SIV
trains used in this study were almost identical to those
eported in the literature (Table 3). Thus we compared
he amino acid sequences of the V1 and V2 regions of
hylogenetically related HIV-2 and SIVmac strains using
he GenBank database. About 20% of amino acids in the
2 region are variable among each of the HIV-2 strains or
IVmac (Table 4). There is a markedly variable region in
he middle of V2, in which the CBL-21 strain (but not the
romiscuous strains) is rich in serines. The V1 se-
Strains Used in This Study
Coreceptor use Cellular CD4-
independent
infectionCR3 CCR5 CCR8 CXCR4 GPR1 APJ
2 2 2 11 2 2 2
2 2 2 11 2 2 2
11 2 1 11 11 1 CXCR4
1 11 11 1 11 1 CCR5a
11 11 11 11 11 11 CXCR4a
11 11 11 11 11 11 CXCR4
2 11 2 1 11 2 2
2 11 2 2 11 2 2
1 11 1 11 11 1 CCR5
and Methods. Dashes are placed at positions where each sequence
ignments. The underlined letter, V in HIV-2ROD sequence, is different
CRs expressed in NP-2/CD4 and NP-2 cells as shown in Fig. 1 are
trains are placed by the order of width of CD4-dependent coreceptorABLE 3
and SIV
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285CD4-DEPENDENT AND CD4-INDEPENDENT INFECTION OF HIV/SIVquences of these HIV-2 strains were much more heter-
ogeneous than were the V3 or V2 sequences (data not
shown). Our sample number may be too small to identify
specific sites that determine the coreceptor usage.
Our findings may be summarized as follows: (1) T-cell-
line-adapted HIV-2 strains were grouped into two types
according to their use of coreceptors other than CXCR4,
and the promiscuous group (SBL6669, GH-1, CBL-23, and
ROD) used multiple GPCRs; (2) this group could infect
either CD4-negative NP-2/CXCR4 or NP-2/CCR5 cells in
the absence (SBL6669 and ROD) or presence (all four
strains) of sCD4; (3) CCR3, CCR8, GPR1, or APJ did not
mediate the CD4-independent infection of HIV-1, HIV-2,
or SIV; (4) GPR1 functioned as a coreceptor for SIVagm
and SIVmnd, and APJ for several HIV-2 strains and
SIVmnd; and (5) SIVmnd infected CD4-negative as well
as CD4-positive NP-2/CCR5 cells. This complicated pat-
tern of the coreceptor use by HIV-2 or SIV still remains to
be clarified. It is also intriguing that HIV-2 showing wide
cell tropism and promiscuous coreceptor usage is less
pathogenic than HIV-1.
MATERIALS AND METHODS
NP-2 cells and sublines
A human glioma cell line, NP-2 (Yamazaki, 1982), and
NP-2 cells stably transduced with human CD4 (NP-2/
CD4) (Shimizu et al., 1995) were cultured in Eagle’s min-
mum essential medium (EMEM) containing 10% fetal
alf serum (FCS). NP-2 and NP-2/CD4 cells stably ex-
ressing human CCR3, CCR5, CCR8, CXCR4, GPR1, or
PJ, and C8166 cells expressing CCR5 (C8166/CCR5)
ere established as described elsewhere (Jinno et al.,
998; Soda et al., 1999). CCR3 and CCR5 were kindly
upplied by T. J. Schall (DNAX Research Institute, Palo
lto, CA) and CXCR4, by K. Matsushima (Tokyo Univer-
ity, Tokyo, Japan). The cDNAs for CCR8, GPR1, and APJ
ere cloned by polymerase chain reaction after reverse
ranscription of cellular mRNA (RT-PCR) as described
T
Comparison of the V2 Amino Acid
Consensus SGLGEEETVN CQFNMTGLER DKKKQYNETW YSKD
. CBL-21 A--EN----D ---------- ------T--- ----
. SBL6669 ---R--DM-E ---------- ------S--- ----
. GH-1 T---K--I-- ---Y------ ---------- ----
. CBL-23 -------V-- ---------- ---------- ----
. ROD --------I- ---------- ---------- ----
. SIVmac T--EQ-QMIG -K------K- --T-E----- --T-
Note. Reported HIV-2 and SIVmac sequences were used for compari
s the consensus sequence. Dashes are placed at positions where i
ntroduced to maintain alignments. There is a markedly heterogeneouJinno et al., 1998; Shimizu et al., 1999a; Soda et al., 1999).
P-2/CD4 cells also express the receptor for ecotropic
(urine leukemia virus as described previously (Jinno et
l., 1998; Soda et al., 1999). The retrovirus vector pMX-
uro (Onishi et al., 1996), containing a cDNA insert for
ach one of the above-listed GPCRs, was transfected
nto fNX-A (Grignani et al., 1998) and BOSC23 (Pear et al.,
993) packaging cells, to make pseudotype virus stocks
o infect NP-2 and C8166 cells, and NP-2/CD4 cells,
espectively. GPCR-transduced NP-2, C8166, and NP-2/
D4 cells were subsequently selected in puromycin-
ontaining medium. The cells that survived were then
sed to examine their susceptibilities to HIV/SIV. The
xpression of mRNA for each GPCR in the puromycin-
esistant sublines was confirmed by RT-PCR with spe-
ific primer pairs for each GPCR cDNA (data not shown).
he expression of CCR3, CCR5, or CXCR4 protein on the
urface of NP-2 or NP-2/CD4 cells transduced with
PCR cDNA-containing pseudotype viruses was deter-
ined by flow cytometry (FCM) using specific monoclo-
al antibodies (MAbs) against CCR3, CCR5, and CXCR4
s described previously (Soda et al., 1999), and results
re summarized in Table 1.
iruses
HIV-2 strains, CBL-20, CBL-21, CBL-23 (Schulz et al.,
990), GH-1 (Ishikawa et al., 1988), and ROD (Clavel et al.,
986), were propagated in Molt-4#8 T cells, and the
BL6669 strain (Albert et al., 1987), in C8166 T cells. SIV
trains agmTYO-1 (Ohta et al., 1988), mac251 (Daniel et
l., 1985), and mndGB-1 (Tsujimoto et al., 1988) were
roduced by acutely infected Molt-4 cells. IIIB, a T-tropic
X4) HIV-1 strain (Popovic et al., 1984), was produced by
ersistently infected Molt-4 cells. GUN1V, an HIV-1 vari-
nt that can infect brain-derived cells such as U87/CD4
nd BT-20/N cells as well as T-cell lines, but hardly
eplicates in macrophages (Shimizu et al., 1994, 1999a,b;
oda et al., 1999; Takeuchi et al., 1991), was propagated
n U87/CD4 cells. Ba-L, an M-tropic (R5) HIV-1 strain
nces of HIV-2 and SIVmac Strains
N NS.T.D.N?. .RCYMNHCNT SVITESCDKH YWDAMRFRYC
S T-V-SKT-WT GK---S---- ---------- ----------
D --.-.-.RK. .--------- ---------- ----------
- -TK..-GKN. .--------- ---------- ----IK----
- GT.-.-T... ..-------- ---------- -------K--
- --.-...-QT .Q-------- ---------- ----I-----
G --.-.-.-ES .--------- -I-Q------ ---TI-----
presentative amino acids at each position among 6 strains are shown
al sequence matches that of the representative sequence; Dotes are
n in the middle: the CBL-21 strain is rich in serines there.ABLE 4
Seque
VVCES
-----
-----
-----
----G
----T
L---Q
son. ReGartner et al., 1986), was prepared from PHA-stimulated
peripheral blood lymphocytes infected with this virus.
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286 LIU ET AL.Flow cytometry (FCM)
Expression of CD4, CCR3, CCR5, or CXCR4 on the
surface of NP-2/CD4/CCR3, NP-2/CD4/CCR5, NP-2/
CD4/CXCR4, NP-2/CCR3, NP-2/CCR5, or NP-2/CXCR4
cells was detected by FCM (Shimizu et al., 1995; Soda
et al., 1999) using the following MAbs: anti-CD4, Nu-
TH/I (Nichirei Bioscience, Tokyo, Japan); anti-CCR3,
7B11 (He et al., 1997); anti-CCR5, 2D7 (He et al., 1997);
and anti-CXCR4, 12G5 (Pharmingen, San Diego, CA)
(Endres et al., 1996). The 7B11 and 2D7 MAbs were
obtained through the AIDS Research and Reference
Reagent Program, AIDS Program, NIAID, NIH. Cells
were then stained with the second antibody (FITC-
conjugated rabbit anti-mouse immunoglobulins). The
cutoff level of fluorescence intensity of each cell line
was determined by which 95% were scored as being
stained negative and by which 5% of the control cells
(stained with the second antibody alone) were scored
as being stained positive, respectively, as described
previously (Shimizu et al., 1995; Soda et al., 1999).
atios of antigen-positive cells (%) were determined as
ollows: percentage of antigen-positive cells 5 per-
entage of cells with fluorescence intensity that was
ver a cutoff value.
nfection assay of cell-free viruses
Reverse transcriptase (RT) activities of the virus
tocks of HIV-1, HIV-2, and SIV strains were deter-
ined as described (Handa et al., 1991). NP-2, NP-2/
D4, and their GPCR-expressing sublines were
eeded into 12- or 24-well culture plates at a density of
–5 3 104 cells/ml. On the following day, the cells were
noculated with viruses, corresponding to an RT activ-
ty of 1 3 105 cpm, at 37°C for 2 h. The cells were
washed and cultured at 37°C for up to 10 days, and the
cells were passaged on Day 5. Culture medium was
changed every 2–3 days. Culture supernatants were
harvested in duplicate on Day 0 (2 h after infection),
Day 3, and Day 5 for RT assays as described before
(Handa et al., 1991). Cell smears were made on slide
lasses to detect viral antigens expressed in infected
ells using indirect immunofluorescence assay (IFA)
Takeuchi et al., 1991): anti-HIV-1 antibody-positive hu-
an serum and antiserum from an SIVmac-infected
acaque, which was confirmed to react with antigens
f HIV-2 and SIV strains used in this experiment, were
sed as the first antibodies. Stained cells were scored
nder a fluorescence microscope as described previ-
usly (Shimizu et al., 1999b; Soda et al., 1999). The
percentages of viral antigen-positive cells (%) were
determined by counting more than 500 cells in three
different fields and were expressed as means 6 stan-
dard deviation (SD).Inhibition of HIV-2 or SIV infection by MAbs or
chemokines
CD4-negative NP-2/CCR5 and NP-2/CXCR4 cells were
seeded as described above and then pretreated with the
indicated concentrations of anti-CCR5 MAb 2D7, anti-
CXCR4 MAb 12G5, or a chemokine (MIP-1a, MIP-1b, or
RANTES) for 1 h at 37°C. The cells were then infected
with HIV-2ROD or SIVmnd (corresponding to an RT ac-
tivity of 1 3 104 cpm) for 2 h and cultured in the medium
containing these MAbs or chemokines for 2 to 3 days at
concentrations half those used for the pretreatment. The
cells were then smeared onto slide glasses for IFA. Viral
antigen-positive cells (%) were determined by IFA as
described above. Inhibition rates (%) were calculated as
follows: Inhibition (%) 5 {1 2 [MAb- or chemokine-
treated culture (IFA-positive, %)/control (IFA-positive,
%)]} 3 100.
Detection for HIV-2 or SIV infection by PCR
PCR was used to detect HIV-2 or SIV DNA synthesis
after infection of NP-2 or NP-2/CD4 cells with these
viruses to estimate virus entry. NP-2 and NP-2/CD4
cells were seeded into 12-well culture plates as de-
scribed above. On the following day, the cells were
inoculated with DNase I-treated viruses for 2 h at
37°C. The cells were then washed with PBS and
cultured at 37°C for 3 days. Cell lysate samples (5 ml)
were amplified by PCR with the primers specific for the
conserved regions flanking the V3 domain of HIV-2,
SIVagm, SIVmac, or SIVmnd. The HIV-2 primers were
JA164F (59-CTTCTACTTGGTTTGGCTTTAATGG-39, nt
6911–6935) and JA165B (59-AATTCTCCTCTGCAGTTT-
GTCCACA-39, nt 7277–7301); SIVagm primers, AgmN
(59-ATCGAACCCAGATATGGCAG-39, nt 6614–6634) and
AgmR (59-ACAAGTTGGATGCTTCTGGG-39, nt 6928–
6948); SIVmac primers, MacN (59-GTGCACCTCCAGG-
TTATGCTTTGCTTAGATG-39, nt 7283–7323) and MacR
(59-CAATTTGTCCACATGAAGGTAACTTCCGGAT-39, nt
7739–7769); and SIVmnd primers, MndN (59-GTAGC-
AATATATCAGCAGTGCAGTGTACTCA-39, nt 6451–6481)
and MndR (59-CATTTGGCAAACTCCTTTTGCTTGTC-
CGTGT-39, nt 6874–6904). The nucleotide sequences
and numbers (nt) were referred to the following Gen-
Bank accession numbers: HIV-2, A05350; SIVagm,
E02137; SIVmac, M76764; and SIVmnd, M27470.
DNA sequencing
The PCR products of HIV/SIV described above were
cloned into a TA cloning vector, pCR2.1 (Invitrogen, Carls-
bad, CA). Clones containing inserts were sequenced
using Texas Red-labeled M13 forward and reverse prim-
ers. A Hitachi SQ-5500 automated DNA sequencer and
software (Hitachi, Tokyo, Japan) were used to determine
DNA sequences as previously described (Jinno et al.,
1998).
CC
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